Literature DB >> 33947705

Self-reported Metabolic Risk Factor Associations with Adenomatous, Sessile Serrated, and Synchronous Adenomatous and Sessile Serrated Polyps.

Celina N Santiago1, Samara Rifkin2, Julia Drewes1,3, Gerard Mullin2, Emma Spence1, Linda M Hylind2, Joell J Gills3,4, David Kafonek5, David M Cromwell5, Louis La Luna6, Francis Giardello2,7,8, Cynthia L Sears.   

Abstract

Studies have found a positive association between metabolic risk factors, such as obesity and diabetes, and adenomatous polyps (AP). However, fewer studies have assessed the association between sessile serrated polyps (SSP) or synchronous diagnosis of APs and SSPs (synch polyps). Study participants (N = 1,370; ages 40-85) undergoing screening colonoscopy were enrolled between August 2016 and February 2020. Self-reported metabolic risk factors, including diabetes, hypertension, hyperlipidemia, and overweight/obesity, were evaluated for associations with new diagnoses of APs, SSPs, and synch polyps at the present colonoscopy. Average participant age was 60.73 ± 8.63 (SD) years; 56.7% were female and 90.9% white. In an assessment of individual metabolic risk factors, adjusted for age, sex, race, and smoking status, increased body mass index (BMI; overweight or obese vs. normal BMI of <25 kg/m2) was associated with an increased odds for new onset of colon APs (P trend < 0.001) as was a diagnosis of diabetes [adjusted conditional OR (aCOR) = 1.59 (1.10-2.29)]. No associations were seen between the metabolic risk factors and onset of SSPs. Being obese or hypertensive each increased the odds of new onset of synch polyps with aCOR values of 2.09 (1.01-4.32) and 1.79 (1.06-3.02), respectively. Self-reported risk factors may help assess polyp type risk. Because SSPs and synch polyps are rare, larger studies are needed to improve our understanding of the contribution of these factors to polyp risk. These data lead us to hypothesize that differences in observed metabolic risk factors between polyp types reflect select metabolic impact on pathways to colorectal cancer. PREVENTION RELEVANCE: Self-reported medical history provides valuable insight into polyp risk, potentially enabling the use of larger retrospective studies of colonoscopy populations to assess knowledge gaps. More aggressive colonoscopy screening, critical to colorectal cancer prevention, may be considered in populations of individuals with metabolic risk factors and modifiable lifestyle risk factors. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2021        PMID: 33947705      PMCID: PMC8295232          DOI: 10.1158/1940-6207.CAPR-20-0664

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  45 in total

1.  Sessile Serrated Polyps with Synchronous Conventional Adenomas Increase Risk of Future Advanced Neoplasia.

Authors:  Erin Symonds; Shahzaib Anwar; Graeme Young; Rosie Meng; Michelle Coats; Kalindra Simpson; Peter Bampton; Robert Fraser; Charles Cock
Journal:  Dig Dis Sci       Date:  2019-01-09       Impact factor: 3.199

2.  Proportion of colon cancer attributable to lifestyle in a cohort of US women.

Authors:  Jennifer Erdrich; Xuehong Zhang; Edward Giovannucci; Walter Willett
Journal:  Cancer Causes Control       Date:  2015-06-20       Impact factor: 2.506

Review 3.  Metformin use and the risk of colorectal adenoma: A systematic review and meta-analysis.

Authors:  Yoon Suk Jung; Chan Hyuk Park; Chang Soo Eun; Dong Il Park; Dong Soo Han
Journal:  J Gastroenterol Hepatol       Date:  2017-05       Impact factor: 4.029

4.  Familial aggregation of diabetes and hypertension in a case-control study of colorectal neoplasia.

Authors:  Paula M Brauer; Gail E McKeown-Eyssen; Vartouhi Jazmaji; Alexander G Logan; David F Andrews; David Jenkins; Norman Marcon; Fred Saibil; Lawrence Cohen; Hartley Stern; David Baron; Gordon Greenberg; Eleftherios Diamandis; Gary Kakis; William Singer; George Steiner
Journal:  Am J Epidemiol       Date:  2002-10-15       Impact factor: 4.897

5.  Association of type 2 diabetes and colon adenomas.

Authors:  Rodney Eddi; Arya Karki; Anish Shah; Vincent A DeBari; Joseph R DePasquale
Journal:  J Gastrointest Cancer       Date:  2012-03

6.  Metabolic syndrome and colorectal neoplasms: An ominous association.

Authors:  Daniel Trabulo; Suzane Ribeiro; Cláudio Martins; Cristina Teixeira; Cláudia Cardoso; João Mangualde; Ricardo Freire; Élia Gamito; Ana L Alves; Fátima Augusto; Ana P Oliveira; Isabelle Cremers
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

7.  Smoking and Other Risk Factors in Individuals With Synchronous Conventional High-Risk Adenomas and Clinically Significant Serrated Polyps.

Authors:  Joseph C Anderson; Audrey H Calderwood; Brock C Christensen; Christina M Robinson; Christopher I Amos; Lynn Butterly
Journal:  Am J Gastroenterol       Date:  2018-11-01       Impact factor: 10.864

8.  The incidence of colorectal cancer in patients with previously removed polyp(s)-a cross-sectional study.

Authors:  Ruud J L F Loffeld; Boris Liberov; Pascale E P Dekkers
Journal:  J Gastrointest Oncol       Date:  2018-08

9.  Type 2 diabetes mellitus and risk of colorectal adenoma: a meta-analysis of observational studies.

Authors:  Feifei Yu; Yibin Guo; Hao Wang; Jian Feng; Zhichao Jin; Qi Chen; Yu Liu; Jia He
Journal:  BMC Cancer       Date:  2016-08-17       Impact factor: 4.430

10.  Calcium channel blockers and cancer: a risk analysis using the UK Clinical Practice Research Datalink (CPRD).

Authors:  Lamiae Grimaldi-Bensouda; Olaf Klungel; Xavier Kurz; Mark C H de Groot; Ana S Maciel Afonso; Marie L de Bruin; Robert Reynolds; Michel Rossignol
Journal:  BMJ Open       Date:  2016-01-08       Impact factor: 2.692

View more
  1 in total

1.  Adult-Attained Height and Colorectal Cancer Risk: A Cohort Study, Systematic Review, and Meta-Analysis.

Authors:  Elinor Zhou; Lin Wang; Celina N Santiago; Julie Nanavati; Samara Rifkin; Emma Spence; Linda M Hylind; Joell J Gills; Louis La Luna; David R Kafonek; David M Cromwell; Julia L Drewes; Cynthia L Sears; Francis M Giardiello; Gerard E Mullin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-04-01       Impact factor: 4.090

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.